DHRM Stock UPDATES Dehaier Medical Systems (DHRM) 5.09 08/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dehaier Medical Systems (DHRM) 5.09 $DHRM

Dehaier Announces the Results of 2014 Shareholder Annual Meeting
GlobeNewswire - Wed Jul 30, 9:07AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced the results of its 2014 annual general meeting of shareholders.

Dehaier Showcases New Sleep Respiratory Solutions at 5th Chinese Sleep Medicine Congress
GlobeNewswire - Mon Jul 21, 8:10AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it showcased the current line of sleep respiratory solution at the 5th Chinese Sleep Medicine Congress ("CSMC" in Nanchang, Jiangxi Province, from July 11-13, 2014.

5 Stocks Ready for Breakouts
at The Street - Fri Jul 11, 1:45PM CDT
These stocks look poised to break out and trade higher from current levels.

Dehaier Medical to Hold Annual General Meeting on July 28, 2014
GlobeNewswire - Mon Jun 30, 5:00PM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, Dehaier Medical reminds shareholders that it will hold its 2014 Annual General Meeting at 9:00 p.m., Eastern Time, on Monday, July 28, 2014 in Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District, Beijing 100856 China.

Dehaier Attends 8th Biennial Chinese Sleep Research Society Conference
GlobeNewswire - Wed Jun 25, 10:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it attended the 8th Biennial Chinese Sleep Research Society ("CSRS" Conference and 20th Anniversary Celebration of CSRS, held in Beijing, from June 13-15, 2014, to showcase its Morpheus OX System and work station.

Dehaier Patented Tele-Consultation Management System V1.0 Software Copyright
GlobeNewswire - Mon Jun 16, 9:38AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it has obtained a software copyright certificate for its Tele-Consultation Management System V1.0 from China's State Copyright Bureau and has received the software product register and test report from the Software Testing Center of China's State Information Center. The Company is applying for software product registration and software company certification and anticipates receiving such registration and certification near year-end.

Dehaier passes CFDA's approval for sale of its Morpheus Ox sleep diagnostic software
M2 - Fri Jun 06, 6:14AM CDT
Medical devices company Dehaier Medical Systems (NasdaqCM HRM) disclosed on Thursday the receipt of the China Food and Drug Administration's (CFDA) approval for the registration of the Morpheus Ox software in assisting with the diagnosis of sleep apnea.

Nasdaq stocks posting largest percentage increases
AP - Thu Jun 05, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Dehaier Receives CFDA Approval for Morpheus Ox Sleep Diagnostic Software
GlobeNewswire - Thu Jun 05, 8:00AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that received approval from the China Food and Drug Administration (CFDA) for its Morpheus Ox software.

Dehaier Medical Announces 2013 Full Year Financial Results
GlobeNewswire - Mon Mar 31, 4:00PM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its 2013 Full Year financial results ended December 31, 2013.

Dehaier Medical Schedules 2013 Full Year Financial Results
GlobeNewswire - Mon Mar 24, 7:05AM CDT
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that the Company plans to release its financial results for the full year of 2013 ended December 31, 2013 on Monday, March 31, 2014, after the stock market closes.

Dehaier Announces Closing of $6.7 Million Registered Direct Offering of Common Shares and Warrants
GlobeNewswire - Wed Feb 26, 8:43AM CST
Dehaier Medical Systems Ltd. (Nasdaq HRM) ("Dehaier" or the "Company" , an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced the closing of a previously announced securities purchase agreement (the "Securities Purchase Agreement" with certain institutional investors for the sale of 734,700 common shares in a registered offering at the price of $9.12 per common share.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading